Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Methodist J.C. Walter Jr. Transplant Center - Houston, TX

Emad H. Asham, M.D., F.R.C.S

Abdominal transplant and Hepatobiliary surgeon

Clinical Expertise

  • Liver, kidney and pancreas transplant surgery

Selected Professional Activity

  • Member, American Society of Transplant surgeons
  • Member, Americas Hepato-pancreato-biliary Asscociation
  • Fellow, the Royal College of Surgeons of England
  • Fellow, the Royal College of Surgeons of Edinburgh
  • Fellow, the Royal College of Surgeons of Glasgow

Research Interest

  • Hepatocellular carcinoma (liver cancer).
  • Minimally invasive surgery approaches in hepatobiliary disease.
  • Clinical trials in immunosuppressive therapies.

Education

  • Clinical Instructorship, University of California Los Angeles
  • Transplantation Surgery fellowship, Starzl Institute, University of Pittsburgh
  • General Surgery residency, University of Massachusetts
  • Doctorate of Medicine, University of London, England.
    Research fellowship, Institute of Surgical Studies, University College London, England.
  • Clinical Lecturer, King's College, London, England.
  • Bachelor of Medicine and Surgery, Assiut University, Egypt.

Dr. Asham's biography

Dr. Asham is an abdominal transplant and hepatobiliary surgeon with clinical expertise in liver, kidney and pancreas transplant surgery, hepatobiliary surgery and liver cancer, and minimally invasive surgery. He completed a general surgery residency at the University of Massachusetts, followed by a fellowship in transplantation surgery at the Starzl Institute at the University of Pittsburgh. Prior to joining the team at Houston Methodist he was a clinical instructor at the University of California at Los Angeles. He is a member of the American Society of Transplant Surgeons and the Americas Hepato-pancreato-biliary Association. His research interests include hepatocellular carcinoma, minimally invasive surgical approaches in hepatobiliary disease and clinical trials in immunosuppressive therapies.